- Home
- PLAY vs QURE Comparison
PLAY vs QURE Comparison
Compare PLAY & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAY
- QURE
- Stock Information
- Founded
- PLAY 1982
- QURE 1998
- Country
- PLAY United States
- QURE Netherlands
- Employees
- PLAY N/A
- QURE N/A
- Industry
- PLAY Restaurants
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- PLAY Consumer Discretionary
- QURE Health Care
- Exchange
- PLAY Nasdaq
- QURE Nasdaq
- Market Cap
- PLAY 678.9M
- QURE 725.4M
- IPO Year
- PLAY 1995
- QURE 2007
- Fundamental
- Price
- PLAY $23.86
- QURE $17.27
- Analyst Decision
- PLAY Buy
- QURE Strong Buy
- Analyst Count
- PLAY 6
- QURE 10
- Target Price
- PLAY $27.25
- QURE $37.20
- AVG Volume (30 Days)
- PLAY 968.9K
- QURE 1.5M
- Earning Date
- PLAY 06-10-2025
- QURE 07-31-2025
- Dividend Yield
- PLAY N/A
- QURE N/A
- EPS Growth
- PLAY N/A
- QURE N/A
- EPS
- PLAY 1.46
- QURE N/A
- Revenue
- PLAY $2,132,700,000.00
- QURE $20,201,000.00
- Revenue This Year
- PLAY $3.48
- QURE $27.16
- Revenue Next Year
- PLAY $5.75
- QURE $248.21
- P/E Ratio
- PLAY $16.34
- QURE N/A
- Revenue Growth
- PLAY N/A
- QURE 6.30
- 52 Week Low
- PLAY $15.08
- QURE $3.73
- 52 Week High
- PLAY $51.30
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- PLAY 62.28
- QURE 67.53
- Support Level
- PLAY $20.75
- QURE $14.75
- Resistance Level
- PLAY $23.85
- QURE $15.50
- Average True Range (ATR)
- PLAY 1.21
- QURE 1.07
- MACD
- PLAY 0.13
- QURE 0.16
- Stochastic Oscillator
- PLAY 98.27
- QURE 93.40
About PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.